Mednet Logo

What cisplatin regimen do you prefer with adjuvant radiation in oropharyngeal SCC that is pT4N2 after surgery and bilateral neck dissection?

Is there data for weekly versus every 3 week cisplatin in this setting?
3 Answers
Mednet Member
Mednet MemberInvited Expert
Medical Oncology · University of Texas MD Anderson Cancer Center
Answered on

Cisplatin 40 mg/m2 weekly.

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Medical Oncology · Valley Med Onc
Answered on

If this cancer was HPV positive, perhaps the patient would have been better off not having surgery.

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Medical Oncology · Florida Cancer Specialists
Answered on

Cisplatin-based chemoradiotherapy continues to be the standard. I personally use 100 mg/m2 every 3 weeks, since it’s the only regimen with randomized phase 3 data. However, I think there is likely no difference on the outcome when using 40 mg/m2 weekly in the adjuvant setting if the dose intensity i...

Join for free or sign in to see the full answer